Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
markets
Globalisation declining? Not in investor portfolios
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,243.30 | 19.10 | -0.23% |
| CAC 40 | 7,589.79 | 42.92 | -0.56% |
| DAX 40 | 18,506.71 | 84.18 | -0.45% |
| Dow JONES (US) | 40,211.72 | 210.82 | 0.53% |
| FTSE 100 | 8,160.52 | 22.44 | -0.27% |
| HKSE | 17,759.38 | 256.56 | -1.42% |
| NASDAQ | 18,472.57 | 74.12 | 0.40% |
| Nikkei 225 | 41,275.08 | 84.40 | 0.20% |
| NZX 50 Index | 12,184.49 | 61.35 | 0.51% |
| S&P 500 | 5,631.22 | 15.87 | 0.28% |
| S&P/ASX 200 | 7,999.30 | 18.30 | -0.23% |
| SSE Composite Index | 2,976.30 | 2.29 | 0.08% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Droneshield Ltd DRO | 2.02 | 0.58 | -22.31% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -2.94% |
| Red 5 Ltd RED | 0.42 | 0.00 | 0.00% |
| Mirvac Group MGR | 2.12 | 0.04 | 1.92% |
| Opthea Ltd OPT | 0.38 | 0.01 | -1.32% |
| Imugene Ltd IMU | 0.06 | 0.00 | -3.51% |
| Telstra Group Ltd TLS | 3.83 | 0.01 | -0.26% |
| Bellevue Gold Ltd BGL | 1.87 | 0.07 | -3.37% |
| Latin Resources Ltd LRS | 0.16 | 0.01 | -5.88% |
| Zip Co Ltd ZIP | 1.61 | 0.03 | 1.90% |